Breast cancer treatment?!
Taken from the $ETST patent:
CLAIMS(30)
CLAIMS What is claimed is:
1. A pharmaceutical composition for use in the treatment of cancer, comprising:
cannabidiol (CBD); and
one or more compounds selected from the group consisting of D-limonene, astaxanthin, malunggay, euphorbia hirta, pao pereira extract, copaiba and ampalaya.
2. The pharmaceutical composition of claim 1, further comprising a pharmaceutically acceptable excipient.
3. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is suitable for oral, parenteral, or topical administration.
4. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition comprises D-limonene.
5. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition comprises astaxanthin.
6. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is used in a cancer treatment that comprises one or more other cancer treatment methods.
7. The pharmaceutical composition of claim 6, wherein the one or more other cancer treatment methods comprise laser photothermal therapy.
8. A pharmaceutical composition for use in the treatment of cancer, comprising:
hemp oil enriched with one or more compounds selected from the group consisting of cannabidiol (CBD), D-limonene, astaxanthin, malunggay, euphorbia hirta, pao pereira extract, copaiba and ampalaya.
9. The pharmaceutical composition of claim 8, wherein the pharmaceutical composition comprises CBD.
10. The pharmaceutical composition of claim 9, further comprising a pharmaceutically acceptable excipient.
1 1. The pharmaceutical composition of claim 9, wherein the pharmaceutical composition is suitable for oral, parenteral, or topical administration.
12. The pharmaceutical composition of claim 9, wherein the pharmaceutical composition further comprises D-limonene.
13. The pharmaceutical composition of claim 9, wherein the pharmaceutical composition further comprises astaxanthin.
14. The pharmaceutical composition of claim 9, wherein the pharmaceutical composition is used in a cancer treatment that comprises one or more other cancer treatment methods.
15. The pharmaceutical composition of claim 14, wherein the one or more other cancer treatment methods comprise laser photothermal therapy.
16. A method of treating breast cancer, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 1.
17. A method of treating breast cancer, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 4.
18. A method of treating breast cancer, comprising: administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 5.
19. A method of treating breast cancer, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 8.
20. A method of treating breast cancer, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 9.
21. A method of modulating the immune system, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 1.
22. A method of modulating the immune system, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 4.
23. A method of modulating the immune system, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 5.
24. A method of modulating the immune system, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 8.
25. A method of modulating the immune system, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 9.
26. A method of providing neuroprotection against reactive oxygen species and lipid peroxidation, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 1.
27. A method of providing neuroprotection against reactive oxygen species and lipid peroxidation, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 4.
28. A method of providing neuroprotection against reactive oxygen species and lipid peroxidation, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 5.
29. A method of providing neuroprotection against reactive oxygen species and lipid peroxidation, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 8.
30. A method of providing neuroprotection against reactive oxygen species and lipid peroxidation, comprising:
administering to a subject in need thereof an effective amount of the pharmaceutical composition of claim 9.
